Qiji Investment
VC Fund
Suzhou, China
Qiji Investment is a professional investment firm that focuses on early-stage investments in the medical and health fields.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Qiji Investment invests in
Stages Qiji Investment invests in
Countries Qiji Investment invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Lily Zhang
|
|||
|
Zhang Li
|
|||
Investment Focus
Industry
- Medical 6 (50%)
- Biotechnology 6 (50%)
- Health Care 4 (33%)
- Pharmaceutical 3 (25%)
- Biopharma 2 (17%)
Stage
- Seed 5 (42%)
- Angel 3 (25%)
- Series A 3 (25%)
- Series B 1 (8%)
Country
- China 7 (58%)
- United States 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Lily Zhang
Founding and Managing partner
|
Founding and Managing partner | Total investments: 0 | Find email | |
|
Zhang Li
Founding & Managing Partner
|
Founding & Managing Partner | Total investments: 6 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Xiaorou Group
|
Xiaorou Group is a company that develops AI-based digital outpatient health service systems for pharmaceutical companies | Series A / Jun 24, 2026 | |
|
Tuosheng Pharmaceuticals
|
Tuosheng Pharmaceuticals is a biotechnology business that develops novel oncology medications and is dedicated to giving cancer patients breakthrough therapy choices. | $40M / Angel / Feb 03, 2026 | |
NeuShen Therapeutics
|
NeuShen Therapeutics is a biotechnology company trailblazing the future treatment of neurological and psychiatric disorders. | Series A / Jan 28, 2026 | |
ALLYRNA Pharmaceuticals
|
ALLYRNA, an innovative small molecule drug developer focused on first-in-class drug development, has established a unique platform for radiotherapy and immunotherapy sensitizers. | $10M / Seed / Aug 27, 2025 | |
Zenitar
|
Baoling Bio is an innovative drug research and development and industrialization service provider. The company's research and development pipeline covers the research and development of innovative drugs such as tumors (solid tumors and hematomas), autoimmune diseases, and cytokine storms caused by new coronavirus pneumonia. | $52.9M / Series B / Aug 05, 2025 | |
Xiaolu Biotech
|
Xiaolu Bio is a biopharmaceutical developer that focuses on the research and development of innovative drugs for autoimmune and inflammatory diseases. | Seed / Jun 17, 2025 | |
Lead Health
|
Lead Health is a hard technology startup company that transforms scientific and technological achievements of the academician team. It independently develops life science instruments and biopharmaceutical equipment and has independent intellectual property rights. | Seed / May 22, 2025 | |
|
Lead Health
|
Lead Health is a hard technology startup company that transforms scientific and technological achievements of the academician team. It independently develops life science instruments and biopharmaceutical equipment and has independent intellectual property rights. | $13.9M / Angel / May 22, 2025 | |
RayThera
|
RayThera focuses on creating innovative small molecule therapies, particularly in the field of immunology, addressing critical unmet medical needs. The company utilizes decades of drug discovery expertise to enhance the development process while upholding stringent standards. | $110M / Series A / Apr 04, 2025 | |
Prime Lifescience
|
Prime Lifescience is a developer of a big data platform that focuses on life sciences. The company is dedicated to establishing a health lifecycle big data collaboration network through digital technology innovation and extensive use of artificial intelligence. They offer a digital smart health community, a digital intelligent clinical researchaccelerator, and a live big data platform as part of their offering. | $14M / Seed / Dec 06, 2023 | |
| See all 12 investments → | |||
Co-Investors
Gaorong Capital
3 deals together
Jiadao Capital
3 deals together
CAS Star
2 deals together
Insight Capital
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Qiji Investment invest in?
Qiji Investment invests primarily in Medical, Biotechnology and Health Care startups, most often at Seed and Angel stage. Most of the 12 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Qiji Investment?
Public channels for Qiji Investment include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Qiji Investment?
The team at Qiji Investment includes Lily Zhang (Founding and Managing partner) and Zhang Li (Founding & Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
